- Remove All
- Your shopping cart is currently empty
- 2256 compounds associated with prostate cancer that can be used for high-throughput and high-content screening.
- Some of the compounds are approved or in clinical phase.
- Detailed instructions, compound structure, target information, activity description, etc.
- Multiple detection techniques such as NMR, HPLC/LCMS to ensure correct structure and high purity of the product and reduce false positives.